The University of Sheffield announces approval of the first human trial testing regenerative cell therapy to treat sensorineural hearing loss, offering hope for restoring hearing function.
Pete Mills, Commercial Technical Operations Manager for Bosch Commercial & Industrial, outlines some of the latest heating technology that could pave the way for net zero in the healthcare sector.
Digital transformation offers many organisations the opportunity to reduce costs, offer superior service and certainly, in Healthcare, improve outcomes. Paul Grosvenor, MD at Optima Systems, an information technology company based in West Sussex, recounts his experiences to date.
Geoff Twist, Managing Director of Roche Diagnostics UK & Ireland, says that the UK's inability to get diagnostic innovation to the frontline is hampering the NHS and the nation's health; this is a missed opportunity.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director, describes why tackling wasted medicines is key to delivering a Net Zero NHS.
More than half of neurointerventionalists, neurosurgeons, neurologists and radiologists are currently experiencing burnout as a result of provider shortages, covering multiple hospitals simultaneously, and increasing demand for emergency stroke care, and this is only expected to get worse.
Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA and APAC at PTC Therapeutics explores how preparing Europe for a new generation of innovative therapies has the potential to transform the lives of patients.
Rob Banathy, Senior Product Manager at NHS Digital, explains how his team developed a lateral flow device digital reader service that can detect nearly twice the number of positive COVID-19 cases during early infection compared to the human eye.
A healthcare data strategy is crucial to ensuring that we can tackle all the biggest health issues we face, and to ensure guided decision-making to save lives.
Diego Angelino, Hjalmar Bardh Olsson & Daniel Eriksson from the TEM Foundation, reveal the Nordic experience when it comes to sustainability in healthcare.
Using almost $30 million in funding, an all-in-one vaccine is being developed to bring new protection against a range of new and existing coronavirus variants.
